{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:05:41Z","timestamp":1769025941831,"version":"3.49.0"},"reference-count":22,"publisher":"BMJ","issue":"6520","license":[{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1986,3,1]]},"DOI":"10.1136\/bmj.292.6520.599","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"599-602","source":"Crossref","is-referenced-by-count":38,"title":["A defence of the small clinical trial: evaluation of three gastroenterological studies."],"prefix":"10.1136","volume":"292","author":[{"given":"J","family":"Powell-Tuck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K D","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Lennard-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1986,3,1]]},"reference":[{"key":"ref_1","first-page":"690","article-title":"The importance of beta, the type II error and sample size in the design and interpretation of the randomised controlled trial","volume":"299","author":"JA, I.Freiman; AB, Thomas; TC, Chalmers; H, Smith; RR, Kuebler","year":"1978","unstructured":"I Freiman JA, Thomas AB, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomised controlled trial. N Engl3'Med 1978;299:690-4."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000198520","article-title":"Effect of nifedipine on oesophageal motility and gastric emptying","volume":"21","author":"Blackwell, J.N.; Holt, S.; Heading, R.C.","year":"1981","unstructured":"Blackwell JN, Holt S, Heading RC. Effect of nifedipine on oesophageal motility and gastric emptying. Digestion 1981;21:50-60.","journal-title":"Digestion"},{"key":"ref_3","first-page":"161","article-title":"kinetics and bioavailability after single intravenous and oral doses in normal subjects. J7 Clin","volume":"23","author":"Foster, T.A.; Hamann, SR, Richards; V.R.","year":"1983","unstructured":"Foster TA, Hamann SR, Richards VR, et al. Nifedipine, kinetics and bioavailability after single intravenous and oral doses in normal subjects.J7 Clin Pharnacol 1983;23:161-70.","journal-title":"Pharnacol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0016-5085(81)90187-6","article-title":"Clinical and manometric effects of nifedipine in patients with esophageal achalasia","volume":"80","author":"Bartolotti, M.; Labo, G.I.","year":"1981","unstructured":"Bartolotti M, Labo GI. Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 1981;80:39-44.","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archinte.1980.00330140105027","article-title":"Colonic motility in the irritable bowel syndrome","volume":"140","author":"Burns, T.W.","year":"1980","unstructured":"Burns TW. Colonic motility in the irritable bowel syndrome. Arch Intemn Med 1980;140:247-51.","journal-title":"Arch Intemn Med"},{"key":"ref_6","article-title":"Effect of nifedipine on colonic motility in the irritable bowel syndrome","volume-title":"Gastroenterology 1983; 84: 1109","author":"Blume, M.; Schuster, M.; Tucker, H.","unstructured":"Blume M, Schuster M, Tucker H. Effect of nifedipine on colonic motility in the irritable bowel syndrome. Gastroenterology 1983;84:1109."},{"key":"ref_7","first-page":"17","article-title":"Calcium channel blocking agents","volume":"1","author":"Leonard, R.G.; Talbert, R.L.","year":"1982","unstructured":"Leonard RG, Talbert RL. Calcium channel blocking agents. Clinical Pharmacy 1982;1: 17-33.","journal-title":"Clinical Pharmacy"},{"key":"ref_8","first-page":"892","article-title":"An experiment to determine the active therapeutic moiety of sulphasalazine","volume":"ii:","author":"KA, Azad Khan; J, Piris; SC, Truelove","year":"1977","unstructured":"Azad Khan KA, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977;ii:892-5.","journal-title":"Lancet"},{"key":"ref_9","first-page":"270","article-title":"Treatment of ulcerative colitis with high dose 5 aminosalicylic acid enemas","volume":"ii:","author":"Campieri, M.; Lanfranchi, G.A.; Bazzocchi, G.","year":"1981","unstructured":"Campieri M, Lanfranchi GA, Bazzocchi G, et al. Treatment of ulcerative colitis with high dose 5 aminosalicylic acid enemas. Lancet 1981;ii:270.","journal-title":"Lancet"},{"key":"ref_10","first-page":"1524","article-title":"Nephrotoxic lesions from 5 aminosalicylic acid","volume":"i:","author":"Calder, I.C.; Fincher, C.C.; Gran, C.R.; Ham, K.N.; Tange, J.D.","year":"1972","unstructured":"Calder IC, Fincher CC, Gran CR, Ham KN, Tange JD. Nephrotoxic lesions from 5 aminosalicylic acid. BrMedJ 1972;i: 1524.","journal-title":"BrMedJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01296733","article-title":"Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis","volume":"27","author":"Powell-Tuck, J.; Day, D.W.; Buckell, N.A.; Wadsworth, J.; Lennard-Jones, J.E.","year":"1982","unstructured":"Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982;27:533-7.","journal-title":"Dig Dis Sci"},{"key":"ref_12","first-page":"260","article-title":"Statistical methodsfor rates and proportions","author":"Fleiss, J.L.","year":"1981","unstructured":"Fleiss JL. Statistical methodsfor rates and proportions. 2nd ed. New York: Wiley, 1981:260-80.","edition":"2nd ed"},{"key":"ref_13","first-page":"193","article-title":"Plasma prednisolone levels after administration of prednisolone 21-phosphate as a retention enema in colitis","volume":"7","author":"Powell-Tuck, J.; Lennard-Jones, J.E.; May, C.S.; Wilson, C.E.; Paterson, J.W.","year":"1976","unstructured":"Powell-Tuck J, Lennard-Jones JE, May CS, Wilson CE, Paterson JW. Plasma prednisolone levels after administration of prednisolone 21-phosphate as a retention enema in colitis. Br Med J7 1976;i: 193-5.","journal-title":"Br Med"},{"key":"ref_14","first-page":"343","article-title":"Diurnal variation in suppression of adrenal function by glucocorticoids","volume":"25","author":"Nichols, T.; Nugent, C.A.; Tyler, F.H.","year":"1965","unstructured":"Nichols T, Nugent CA, Tyler FH. Diurnal variation in suppression of adrenal function by glucocorticoids.Joumnal ofClinical Endocrinologo 1965;25:343-9.","journal-title":"Joumnal ofClinical Endocrinologo"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/ard.30.2.149","article-title":"Single daily dose corticosteroid treatment: effect of adrenal function and therapeutic efficacy in various diseases","volume":"30","author":"Myles, A.B.; Bacon, P.A.; Daly, JR","year":"1971","unstructured":"Myles AB, Bacon PA, Daly JR. Single daily dose corticosteroid treatment: effect of adrenal function and therapeutic efficacy in various diseases. Ann Rheum Dis 1971;30:149-53.","journal-title":"Ann Rheum Dis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/gut.19.1.64","article-title":"Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis","volume":"19","author":"Farthing, M.J.G.; Lennard-Jones, J.E.","year":"1978","unstructured":"Farthing MJG, Lennard-Jones JE. Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut 1978;19:64-9.","journal-title":"Gut"},{"key":"ref_17","first-page":"561","article-title":"Comparison oforal and rectal steroids in the treatment of proctocolitis","volume":"57","author":"Misiewicz, J.J.; Connell, A.M.; Lennard-JonesJE, Jones; F.A.","year":"1964","unstructured":"Misiewicz JJ, Connell AM, Lennard-JonesJE, Jones FA. Comparison oforal and rectal steroids in the treatment of proctocolitis. Proceedings ofthe Royal Society ofMedicine 1964;57:561-2.","journal-title":"Proceedings ofthe Royal Society ofMedicine"},{"key":"ref_18","first-page":"84","article-title":"Betamethasone 17 valerate and prednisolone 21-phosphate retention enemata in proctocolitis","volume":"iii:","author":"Trial, Multicentre","year":"1971","unstructured":"Multicentre Trial. Betamethasone 17 valerate and prednisolone 21-phosphate retention enemata in proctocolitis. BrMedJ 1971;iii:84-6.","journal-title":"BrMedJ"},{"key":"ref_19","article-title":"Statistical methods in medical research","author":"Armitage, P.","year":"1971","unstructured":"Armitage P. Statistical methods in medical research. Oxford: Blackwell, 1971."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0197-2456(80)80004-3","article-title":"Statistical controversies in the design of clinical trials-some personal views","volume":"1","author":"Brown, B.W.","year":"1980","unstructured":"Brown BW. Statistical controversies in the design of clinical trials-some personal views. Controlled Clin Trials 1980;1:13-27.","journal-title":"Controlled Clin Trials"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-2456(82)90024-1","article-title":"\"Proving the null hypothesis\" in clinical trials","volume":"3","author":"Blackwelder, W.C.","year":"1982","unstructured":"Blackwelder WC. \"Proving the null hypothesis\" in clinical trials. Controlled Clin Trials 1982;3:345-53.","journal-title":"Controlled Clin Trials"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0021-9681(67)90041-0","article-title":"Explanatory and pragmatic attitudes in therapeutic trials","volume":"20","author":"Schwartz, D.; Lellouch, J.","year":"1967","unstructured":"Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials.Jy Chronic Dis 1967;20:637-48.","journal-title":"Jy Chronic Dis"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.292.6520.599","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.292.6520.599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:26:38Z","timestamp":1765484798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.292.6520.599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,3,1]]},"references-count":22,"journal-issue":{"issue":"6520","published-online":{"date-parts":[[1986,3,1]]},"published-print":{"date-parts":[[1986,3,1]]}},"alternative-id":["10.1136\/bmj.292.6520.599"],"URL":"https:\/\/doi.org\/10.1136\/bmj.292.6520.599","relation":{},"ISSN":["0267-0623","1468-5833"],"issn-type":[{"value":"0267-0623","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,3,1]]}}}